American Heart Journal
Volume 152, Issue 4 , Pages 641-647, October 2006

Prevalence, predictors, and outcomes of patients with non–ST-segment elevation myocardial infarction and insignificant coronary artery disease: Results from the Can Rapid risk stratification of Unstable angina patients Suppress ADverse outcomes with Early implementation of the ACC/AHA Guidelines (CRUSADE) initiative

  • Manesh R. Patel, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • Corresponding Author InformationReprint requests: Manesh R. Patel, MD, PO Box 17969, Duke Clinical Research Institute, Durham, NC 27705.
    • ,
  • Anita Y. Chen, MS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • L. Kristin Newby, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Charles V. Pollack Jr., MD, MA

      Affiliations

    • Pennsylvania Hospital, University of Pennsylvania School of Medicine, Philadelphia, PA
    • ,
  • Ralph G. Brindis, MD, MPH

      Affiliations

    • San Francisco Kaiser Permanente Hospital, San Francisco, CA
    • ,
  • C. Michael Gibson, MD

      Affiliations

    • Harvard Clinical Research Institute, Boston, MA
    • ,
  • Neal S. Kleiman, MD

      Affiliations

    • Section of Cardiology, Baylor College of Medicine, Oklahoma City, OK
    • ,
  • Jorge F. Saucedo, MD

      Affiliations

    • University of Oklahoma Health Sciences Center, Oklahoma City, OK
    • ,
  • Deepak L. Bhatt, MD

      Affiliations

    • Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, OH
    • ,
  • W. Brian Gibler, MD

      Affiliations

    • University of Cincinnati School of Medicine, Cincinnati, OH
    • ,
  • E. Magnus Ohman, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Robert A. Harrington, MD

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Division of Cardiology and Duke Clinical Research Institute, Duke University Medical Center, Durham, NC

Received 17 June 2005; accepted 5 February 2006. published online 30 June 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 CRUSADE is a national quality improvement initiative of the Duke Clinical Research Institute. CRUSADE is funded by the Schering-Plough Corporation, Kenilworth, NJ. Bristol-Myers Squibb, New York, NY/Sanofi-Aventis Pharmaceuticals, Paris, France. Partnership provides additional funding support. Millennium Pharmaceuticals, Inc., Cambridge, MA, also funded this work.

PII: S0002-8703(06)00254-7

doi:10.1016/j.ahj.2006.02.035

American Heart Journal
Volume 152, Issue 4 , Pages 641-647, October 2006

Article Tools